ADAMTS13 and thrombotic thrombocytopenic purpura: A standardized diagnostic process and management of TTP/TMA patients is hampered by the rarity of the disease and the long turn-around time of ADAMTS13 testing, which might take days due to the technical characteristics of currently available assays, that are unsuitable for emergency laboratories and usually limited to specialized centers [21].